# OnCo record bd-onclarity-hpv (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/bd-onclarity-hpv/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "bd-onclarity-hpv" ;
  schema:name "BD Onclarity HPV Assay (extended genotyping)"@en ;
  schema:alternateName "Onclarity HPV"@en, "BD Onclarity"@en, "BD Onclarity HPV" ;
  schema:description "BD's laboratory HPV test, approved in 2018, which since 2024 names six high-risk virus types separately, helping decide who needs colposcopy, and accepts samples women take themselves."@en ;
  schema:url <https://onco.cc/drugs/bd-onclarity-hpv/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160037> ;
  onco:status "approved" ;
  onco:tag "test", "screening-test" ;
  onco:modality "HPV DNA test (PCR) with extended genotyping, for cervical screening" ;
  onco:approval "US 2018: Detection of 14 high-risk HPV types in cervical specimens (PMA P160037)" ;
  onco:related <https://onco.cc/drugs/cobas-hpv/>, <https://onco.cc/drugs/bd-surepath/>, <https://onco.cc/drugs/alinity-m-hr-hpv/>, <https://onco.cc/collections/fda-device-databases/> ;
  onco:cancers <https://onco.cc/cancers/cervical/> ;
  onco:sections <https://onco.cc/fronts/early-detection/>, <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/hpv-testing/> ;
  onco:companies <https://onco.cc/companies/becton-dickinson/> ;
  onco:terms <https://onco.cc/terms/cin-hsil/>, <https://onco.cc/terms/screening/> .